Physician

Bishow Chandra Shrestha, MD

According to 2025 Medicare claims, Bishow Shrestha, MD (NPI: 1336422286) practices endocrinology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1578623781; TIN: 23-2730785) and primary practice location at 17325-7878. Shrestha is affiliated with the WellSpan Population Health Services (ACO ID: A2500) and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Shrestha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 198 traditional Medicare patients, billed 3,637 HCPCS/CPT codes, and received $86,039 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,461 prescription claims across 267 beneficiaries totaling $974,802 in drug costs, led by Ozempic (Semaglutide). DME data shows 128 claims. Open Payments data shows 2 records totaling $52. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $54,921 and ending at $86,039. Concurrently, Part D prescription costs have risen steadily, from $15,669 to $974,802. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $9,999 and ending at $63,841.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	250	814	$54,921
2016	224	714	$46,204
2017	274	847	$58,911
2018	215	626	$48,032
2019	360	1,012	$83,589
2020	90	267	$20,435
2021	N/R	N/R	N/R
2022	20	24	$2,600
2023	168	3,604	$67,063
2024	198	3,637	$86,039

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	221	$15,669
2016	65	163	$6,434
2017	58	175	$7,936
2018	47	183	$36,809
2019	72	134	$9,747
2020	23	40	$3,599
2021	N/R	N/R	N/R
2022	16	22	$1,218
2023	199	1,012	$456,775
2024	267	2,461	$974,802

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	71	$4,503
2016	N/R	61	$11,531
2017	N/R	11	$26
2018	N/R	N/R	N/R
2019	N/R	83	$3,422
2020	N/R	40	$1,211
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	33	108	$21,591
2024	36	128	$57,454

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	77	114	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	263	$83
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	41	79	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	33	36	$10
82962	Blood glucose (sugar) test performed by hand-held instrument	47	63	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	282	10,957	$315,591
Trulicity	Dulaglutide	170	5,690	$189,664
Jardiance	Empagliflozin	93	4,890	$90,756
Tradjenta	Linagliptin	72	3,120	$51,200
Mounjaro	Tirzepatide	27	1,040	$35,330

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	36	128	$57,454

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$52	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bishow Chandra Shrestha, MD?

Tedicare shows public-source Medicare data for Bishow Chandra Shrestha, MD (NPI 1336422286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bishow Chandra Shrestha, MD have ACO affiliation data?

Bishow Chandra Shrestha, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500) and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Bishow Chandra Shrestha, MD?

Bishow Chandra Shrestha, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1578623781) in the available physician profile data.

Does Bishow Chandra Shrestha, MD have Open Payments data?

Bishow Chandra Shrestha, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.